Cargando…
Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation
With the development of nanotechnology, significant progress has been made in the design, and manufacture of nanoparticles (NPs) for use in clinical treatments. Recent increases in our understanding of the central role of macrophages in the context of inflammation and cancer have reinvigorated inter...
Autores principales: | Hu, Guorong, Guo, Mengfei, Xu, Juanjuan, Wu, Feng, Fan, Jinshuo, Huang, Qi, Yang, Guanghai, Lv, Zhilei, Wang, Xuan, Jin, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712945/ https://www.ncbi.nlm.nih.gov/pubmed/31497026 http://dx.doi.org/10.3389/fimmu.2019.01998 |
Ejemplares similares
-
Retinoic Acid Receptor-Related Orphan Receptors: Critical Roles in Tumorigenesis
por: Fan, Jinshuo, et al.
Publicado: (2018) -
Comprehensive genomic and prognostic analysis of the IL-17 family genes in lung cancer
por: Liao, Tingting, et al.
Publicado: (2019) -
The Role of Interleukin-17 in Lung Cancer
por: Wu, Feng, et al.
Publicado: (2016) -
The ACE2/Angiotensin-(1–7)/Mas Receptor Axis: Pleiotropic Roles in Cancer
por: Xu, Juanjuan, et al.
Publicado: (2017) -
Targeting of Hepatic Macrophages by Therapeutic Nanoparticles
por: Colino, Clara I., et al.
Publicado: (2020)